Table 3.
Characteristic | Unadjusted | Adjusted¶ | ||
---|---|---|---|---|
HR | 95% CI | aHR | 95% CI | |
Age (years) | ||||
15–25 | 1.0 | 1.0 | ||
26–35 | 1.6 | 1.3–1.9 | 1.6 | 1.0–2.4 |
36–45 | 2.1 | 1.8–2.5 | 1.6 | 1.2–2.2 |
45+ | 2.2 | 1.7–2.6 | 1.3 | 0.9–2.0 |
Sex | ||||
Females | 1.0 | 1.0 | ||
Males | 2.4 | 2.2–2.6 | 1.8 | 1.7–1.9 |
Marital status | ||||
Single | 1.0 | 1.0 | ||
Married/co-habiting | 0.8 | 0.7–0.9 | 0.9 | 0.8–1.0 |
Widowed/divorced | 1.1 | 1.0–1.2 | 0.9 | 0.8–1.1 |
BMI categories (Kg/m2) | ||||
Underweight (< 18.5) | 2.5 | 2.3–2.7 | 1.8 | 1.5–2.1 |
Normal (18.5–24.5) | 1.0 | 1.0 | ||
Overweight (25–29.9) | 0.5 | 0.4–0.6 | 0.7 | 0.6–0.8 |
Obese (≥30) | 0.4 | 0.3–0.4 | 0.5 | 0.4–0.7 |
CD4 categories (cells/μl) | ||||
< 200 | 1.0 | 1.0 | ||
200–350 | 0.5 | 0.5–0.6 | 0.7 | 0.6–0.8 |
> 350 | 0.3 | 0.3–0.4 | 0.5 | 0.4–0.6 |
WHO clinical staging of HIV | ||||
I | 1.0 | 1.0 | ||
II | 2.0 | 1.7–2.3 | 1.4 | 1.2–1.6 |
III | 4.4 | 3.9–5.0 | 2.7 | 2.2–3.2 |
IV | 5.3 | 4.5–6.1 | 2.6 | 1.8–3.9 |
Cotrimoxazole use | ||||
No | 1.0 | 1.0 | ||
Yes | 2.4 | 1.9–3.1 | 2.2 | 1.3–3.9 |
IPT status | ||||
Ever | 0.7 | 0.6–0.7 | 0.6 | 0.4–0.9 |
Never | 1.0 | |||
ART status | ||||
Ever | 2.6 | 2.1–3.1 | 1.5 | 1.0–2.2 |
Never | 1.0 | 1.00 | ||
Functional status at enrolment | ||||
Working | 1.0 | 1.0 | ||
Bedridden | 1.8 | 1.2–2.8 | 2.5 | 2.0–3.2 |
Ambulatory | 6.1 | 5.3–7.0 | 1.2 | 0.4–3.2 |
adjusted for the effect of age, sex, BMI, CD4 count, WHO stage, IPT use, ART status and Functional status at enrollment